| Date Filed | Type | Description |
| 12/07/2012 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/13/2012 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)] |
| 11/02/2012 |
8-K
| Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa... |
| 11/02/2012 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/01/2012 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 11/01/2012 |
SC TO-T/A
| Form SC TO-T - Tender offer statement by Third Party [amend] |
| 11/01/2012 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
| 10/17/2012 |
SC TO-T/A
| Form SC TO-T - Tender offer statement by Third Party [amend] |
| 10/16/2012 |
SC TO-T/A
| Form SC TO-T - Tender offer statement by Third Party [amend] |
| 10/10/2012 |
SC TO-T/A
| Form SC TO-T - Tender offer statement by Third Party [amend] |
| 10/10/2012 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 09/28/2012 |
SC TO-T/A
| Form SC TO-T - Tender offer statement by Third Party [amend] |
| 09/20/2012 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party |
| 09/20/2012 |
GN
| IRIS International to Present NADiA ProsVue at Two Important Meetings in Washington DC Addressing the Role of Advanced Diagnostics in Cancer |
| 09/18/2012 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 09/17/2012 |
8-K
| Quarterly results |
| 09/17/2012 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party |
| 09/17/2012 |
GN
| IRIS International Announces Agreement to be Acquired by Danaher Corporation for $19.50 per Share |
| 08/09/2012 |
10-Q
| Quarterly Report for the period ended June 30, 2012 |
| 07/31/2012 |
8-K
| Quarterly results |
| 07/19/2012 |
GN
| IRIS to Release Second Quarter Financial Results and Host Conference Call and Webcast on Tuesday, July 31 |
| 07/17/2012 |
GN
| IRIS International Announces Distribution Agreement With Alifax and Launch of ESR Automated Instrumentation |
| 06/06/2012 |
GN
| IRIS International Announces Clinical Data Presentation of NADiA(R) ProsVue(TM) Benefits at the 5th International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer |
| 05/25/2012 |
GN
| IRIS International to Present at Upcoming Investor Conferences |
| 05/21/2012 |
GN
| IRIS International Unveils NADiA(R) ProsVue(TM) at the American Urological Association (AUA) Annual Meeting, May 19-24, 2012 |
| 05/10/2012 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans |
| 05/10/2012 |
10-Q
| Quarterly Report for the period ended March 31, 2012 |
| 05/02/2012 |
8-K
| Quarterly results |
| 05/02/2012 |
GN
| IRIS International Announces First Quarter 2012 Revenue and Financial Results |
| 04/11/2012 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 04/10/2012 |
GN
| IRIS International Reports Granting of Inducement Awards |
| 03/19/2012 |
GN
| IRIS International Commences Commercial Shipment of ThermoBrite(R) Elite |
| 03/12/2012 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/12/2012 |
10-K
| Annual Report for the period ended December 31, 2011 |
|